Development of covalent inhibitors against Mpro derived from SARS-CoV2

Daichi Chida

[2P-591] Development of covalent inhibitors against Mpro derived from SARS-CoV2

^〇Daichi Chida¹, Yuya Habuka¹, Takashi Toyama¹, Takaaki Akaike², Mieko Arisawa³, Masana Yazaki³, Yoshiro Saito¹ (1.Graduate School of Pharmaceutical Sciences, Tohoku University, 2.Graduate School of Medicine, Tohoku University, 3.Graduate School of Agronomy, Kyushu University)

キーテクノロジー：酵素活性測定

Ebselen、Main protease、COVID-19

Contents of this site has moved to the member page of The Japanese Biochemical Society: https://member.jbsoc.or.jp/mypage/
You can access the abstracts without credentials by accessing them via the member page.

You need the membership number and password to access the member page. Please contact the journal office for any inquiries.

Journal Office Contact Information:
E-mail:jbs-ho@jbsoc.or.jp
Tel:03(3815)1913 Fax:03(3815)1934

The 96th Annual Meeting of the Japanese Biochemical Society

[2P-591] Development of covalent inhibitors against Mpro derived from SARS-CoV2

Password